BLACK DIAMOND THERAPEUTICS

black-diamond-therapeutics-logo

Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small-molecule. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform namely, Mutation-Allostery-Pharmacology which is targeting mutations in cancer. Black Diamond focused on the discovery and development of precision medicines for cancer that is directed against a novel class of allosteric mutant oncogenes. The company targets undrugged mutations in patients with genetically defined cancers for whom limited treatment options currently exist. It is built upon a deep understanding of cancer genetics, protein structure and function, and medicinal chemistry.

#SimilarOrganizations #People #Financial #Event #Website #More

BLACK DIAMOND THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science Medical

Founded:
2017-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.blackdiamondtherapeutics.com

Total Employee:
11+

Status:
Active

Contact:
617-417-5868

Email Addresses:
[email protected]

Total Funding:
197.1 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Microsoft Exchange Online Organization Schema Office 365 Mail IPv6


Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.


Current Advisors List

samarth-kulkarni_image

Samarth Kulkarni Board Member @ Black Diamond Therapeutics
Board_member
2019-12-01

Current Employees Featured

david-m-epstein_image

David M. Epstein
David M. Epstein Founder, President & Chief Executive Officer @ Black Diamond Therapeutics
Founder, President & Chief Executive Officer

alexander-mayweg_image

Alexander Mayweg
Alexander Mayweg Founding, Chief Scientific Officer @ Black Diamond Therapeutics
Founding, Chief Scientific Officer

christopher-roberts_image

Christopher Roberts
Christopher Roberts Chief Scientific Officer @ Black Diamond Therapeutics
Chief Scientific Officer

sergey-yurasov_image

Sergey Yurasov
Sergey Yurasov Chief Medical Officer @ Black Diamond Therapeutics
Chief Medical Officer
2022-06-01

elizabeth-montgomery_image

Elizabeth Montgomery
Elizabeth Montgomery Chief People Officer @ Black Diamond Therapeutics
Chief People Officer
2022-02-01

elizabeth-buck_image

Elizabeth Buck
Elizabeth Buck Founder, Executive Vice President @ Black Diamond Therapeutics
Founder, Executive Vice President
2015-01-01

brent-hatzis-schoch_image

Brent Hatzis-Schoch
Brent Hatzis-Schoch COO and General Counsel @ Black Diamond Therapeutics
COO and General Counsel

Founder


alexander-mayweg_image

Alexander Mayweg

david-m-epstein_image

David M. Epstein

elizabeth-buck_image

Elizabeth Buck

Stock Details


Company's stock symbol is NASDAQ:BDTX

Investors List

nextech-invest_image

Nextech Invest

Nextech Invest investment in Series C - Black Diamond Therapeutics

bvf-partners_image

BVF Partners

BVF Partners investment in Series C - Black Diamond Therapeutics

logos-capital_image

Logos Capital

Logos Capital investment in Series C - Black Diamond Therapeutics

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Series C - Black Diamond Therapeutics

invus_image

Invus

Invus investment in Series C - Black Diamond Therapeutics

wellington-management_image

Wellington Management

Wellington Management investment in Series C - Black Diamond Therapeutics

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series C - Black Diamond Therapeutics

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series C - Black Diamond Therapeutics

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Series C - Black Diamond Therapeutics

city-hill-ventures_image

City Hill Ventures

City Hill Ventures investment in Series C - Black Diamond Therapeutics

Official Site Inspections

http://www.blackdiamondtherapeutics.com Semrush global rank: 3.73 M Semrush visits lastest month: 3.67 K

  • Host name: cloudhost-10606077.us-midwest-2.nxcli.net
  • IP address: 199.189.225.244
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Black Diamond Therapeutics" on Search Engine